Home About Clinical Research News Insights Podcasts Videos SCOPE Events

Stay Connected to Clinical Research—All Year Long

SCOPE 365 is the year-round digital extension of SCOPE, bringing clinical research professionals continuous access to insights, live virtual meetups, expert interviews, and premium intelligence products. It’s a centralized hub designed to help sponsors, CROs, sites, and solution providers stay on the pulse of the industry, elevate thought leadership, and maintain momentum between SCOPE’s global conferences.

Latest In Clinical Trials

India Can Surpass China in Global Pharma. But Not Where Most People Think.

Clinical Research News | India has long been called the pharmacy of the world. That reputation was earned through manufacturing scale, generics leadership, and the ability to supply medicines globally at extraordinary volume. But the next chapter for India’s pharmaceutical industry will be different. Recent industry discussion about India’s pharmaceutical ambitions has largely explored one question: Can India compete with China as a global pharmaceutical power? more...

June 26, 2026
Beyond Startup: Building Sponsor-Site Partnerships That Last

Insights from SCOPE | Strong sponsor-site partnerships don't begin with startup and end at closeout. Discover how long-term collaboration, operational transparency, and shared learning can reduce friction, improve trial execution, and create lasting value across every study in a development portfolio. more...

June 25, 2026
Clinical Trial Startup Is Slowing Down. Here's Why.

Insights from SCOPE | Clinical trial startup continues to slow despite growing investment in technology and automation. Explore how protocol complexity, fragmented processes, incomplete operational visibility, and internal misalignment create delays—and why removing friction may matter more than adding new tools. more...

June 23, 2026
Novo Nordisk Clinical Trial Data Targeted in Data Attack

Clinical Research News | In mid-June Novo Nordisk announced, “an IT security incident involving unauthorized access to a limited number of internal IT systems” that exposed personal information for clinical trial participants. Novo Nordisk listed the exposed data categories as Patient ID (random alphanumeric string) and information on trial participation; sex; year of birth; biomarkers; health/immunogenicity data; and lifestyle factors including smoking, alcohol use, and BMI. more...

June 23, 2026
Building Recruitment Systems Instead of Recruitment Campaigns

Insights from SCOPE | Many enrollment challenges begin long before patient outreach starts. Explore why protocol design, site feasibility, community engagement, and patient support function as a connected recruitment system—and why stronger systems often matter more than bigger campaigns. more...

June 18, 2026
Moving from Active to Autonomous TMF with Agentic AI

Clinical Research News | For years, TMF leaders advocated for active TMF, a model where the TMF is a "place to go to do your work" instead of a passive archive. The shift to active TMF made significant progress for life sciences, moving toward applications that deliver real-time trial execution and TMF management. With the introduction of agentic AI in clinical trials, TMF management is now evolving from active to autonomous. more...

June 18, 2026